The Classification and Treatment of Myofascial Headache: a Cross-sectional Study and Randomized Controlled Trial.
COMPHAS_RCT
The Classification of Myofascial Headache: a Cross-sectional Study. the Added Value of Dry Needling in the Treatment of Myofascial Headache: a Randomized Controlled Trial.
1 other identifier
interventional
152
1 country
1
Brief Summary
This project comprises two studies; a cross-sectional study and a randomized controlled trial.
- Are the criteria drafted by the International Classification of Headache Disorders (ICHD) discriminative for MFH?
- Are there differences between the headache types (and healthy controls) in pain \& disability scores, range of motion (ROM), muscle strength, muscle elasticity and hyperalgesia (=pain pressure threshold, PPT)? Participants will :
- Fill out questionnaires about their pain and disability;
- Be clinically investigated by a physiotherapist (anamnesis, inspection, examination of movement and structures of the neck and head);
- Undergo a testing battery including neck ROM, neck muscle strength \& elasticity and PPT measurement of the C2 processus spinosus, the bilateral upper trapezius muscle and the tibialis anterior muscle of the dominant leg.
- The goal of this randomized controlled study is to investigate the additional effect of dry needling in the treatment of MFH patients, as compared to a treatment consisting of manual techniques only. The main question it aims to answer is:
- Does manual therapy combined with dry needling provide an additional effect on pain, disability and functional outcomes in MFH patients, as compared to manual therapy alone? After the baseline test (see part 1), participants with MFH will be randomly divided to receive 4 sessions over 4 weeks of MT or MT + DN. Hereafter, the baseline test is repeated at 1 week and 3 months post-treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 20, 2023
CompletedFirst Posted
Study publicly available on registry
October 25, 2023
CompletedStudy Start
First participant enrolled
December 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
September 19, 2024
September 1, 2024
4 years
October 20, 2023
September 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Headache Disability Inventory (HDI)
The HDI is a 25-item questionnaire of which the questions focus on two categories. There are 13 questions related to the emotional effects and 12 questions on the functional effects of headache complaints. There are 3 answer options: yes (4 points), sometimes (2 points), no (0 points). The sum (maximum 100) gives an impression about the self-perceived limitations as a result of headache. The higher the score, the greater the hindrance caused by headache.
Baseline; 1 week, 3 months, 6 months, 12 months post-treatment
Secondary Outcomes (12)
Neck Disability Index (NDI)
Baseline; 1 week, 3 months, 6 months, 12 months post-treatment
Numeric Pain Rating Scale (NPRS)
Baseline; right before each treatment session; 1 week, 3 months, 6 months, 12 months post-treatment
Range of Motion (ROM)
Baseline; 1 week and 3 months post-treatment
Muscle strength (Fm)
Baseline; 1 week and 3 months post-treatment
Pressure Pain Threshold (PPT)
Baseline; 1 week and 3 months post-treatment
- +7 more secondary outcomes
Study Arms (2)
MT + DN
EXPERIMENTAL4 treatment sessions of 20 minutes manual therapy will be given over 4 weeks (1session/week). The techniques will be tailored to the patients needs, and will exclude 'High Velocity Low Amplitude' manipulations. In addition, a maximum of 4 muscles will be treated by means of dry needling in at least 3 sessions, based on the pain pattern of the patient.
MT alone
ACTIVE COMPARATOR4 treatment sessions of 20 minutes manual therapy will be given over 4 weeks (1session/week). The techniques will be tailored to the patients needs, and will exclude 'High Velocity Low Amplitude' manipulations.
Interventions
Dry needling (DN) is a myofascial treatment technique, in which a thin, solid filiform needle is inserted directly into the MTrP. During dry needling, local twitch responses (LTR) can be elicited. These are involuntary contractions of muscle fibers, leading to muscle relaxation, an increase in blood flow,recovery of the muscle metabolism and thus a reduction of pain and stiffness.
Manual therapy comprises stretching of muscles, mobilizations, traction and translation of vertebrae, Sustained Natural Apophyseal Glides (SNAG), dynamic soft tissue mobilization, Muscle Energy Techniques (MET) and home-exercises.
Eligibility Criteria
You may qualify if:
- \< 15 headache days per month
- \> 5 episodes of the headache that gives hindrance
- Mean NPRS score for headache episodes \>2/10
- No history of whiplash
- No serious structural pathology
- No previous surgeries in the head/neck/shoulder region
- To be included in the RCT-part of the study:
- \- Fitting the ICHD criteria for MFH
You may not qualify if:
- Diagnosis of migraine by a neurologist or as confirmed via the Headache Screening Questionnaire (HSQ) with the maximum score of 8/8.
- Chronic headache (\>15 headache days/month)
- Newly onset headache (\<5 previous episodes of new headache type)
- Whiplash or whiplash associated disorders
- Serious structural pathology (confirmed by medical imaging)
- Pain on both sides of the body, above and under the waist, (with a total score of 7 or more out of 10) (=Widespread pain)
- Cardiovascular/metabolic/systemic/neurological diseases
- Fibromyalgia, Chronic Fatigue Syndrome
- History of surgery in the head/neck or shoulder region
- Probable or definite neuropathic pain (according to the classification of Finnerup et al.)
- Traumatic onset of the complaints
- Pregnancy/given birth/breastfeeding in the preceding year
- Psychiatric illnesses or depression diagnosed by a psychiatrist and currently treated by a psychiatrist and/or medication.
- BMI \>30
- Usage of heavy blood thinners or anti-coagulants (e.g. Marcoumar, Marevan, Sintrom)
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Ghentlead
Study Sites (1)
Universitair ziekenhuis Gent
Ghent, Oost-Vlaanderen, 9000, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barbara Cagnie, Prof. Dr.
University Ghent
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 20, 2023
First Posted
October 25, 2023
Study Start
December 6, 2023
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
September 19, 2024
Record last verified: 2024-09